Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:monoclonal_antibody |
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
L01XC08
|
| gptkbp:brand |
Vectibix
|
| gptkbp:CASNumber |
339177-26-3
|
| gptkbp:contraindication |
gptkb:KRAS_mutation
|
| gptkbp:developedBy |
gptkb:Amgen
|
| https://www.w3.org/2000/01/rdf-schema#label |
panitumumab
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:macromoleculeType |
gptkb:IgG2
|
| gptkbp:mechanismOfAction |
EGFR inhibition
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
diarrhea
skin rash hypomagnesemia |
| gptkbp:target |
gptkb:EGFR
|
| gptkbp:UNII |
IY9XDZ35W2
|
| gptkbp:usedFor |
colorectal cancer
|
| gptkbp:bfsParent |
gptkb:EGFR_gene
gptkb:P15056 gptkb:P42338 |
| gptkbp:bfsLayer |
6
|